BusinessNeothetics to Provide a Business Update and Release Fourth Quarter 2016 Financial Results Thursday, March 23, 2017By Nasdaq OMXMar 16, 2017, 12:00 PM UTC
BusinessNeothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous FatBy Nasdaq OMXDec 23, 2016, 1:00 PM UTC
BusinessNeothetics Provides Business Update and Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 10, 2016, 1:00 PM UTC
BusinessNeothetics to Present at the 15th Annual Needham Healthcare ConferenceBy Nasdaq OMXApr 6, 2016, 12:00 PM UTC
BusinessNeothetics Reports Fourth Quarter 2015 Financial ResultsBy Nasdaq OMXMar 29, 2016, 12:00 PM UTC
BusinessNeothetics Provides Update and Plan Forward for LIPO-202 ProgramBy Nasdaq OMXMar 28, 2016, 12:00 PM UTC
BusinessNeothetics Announces Leadership Change and Preliminary Update on LIPO-202By Nasdaq OMXFeb 18, 2016, 9:00 PM UTC
